Federal judge tosses ESC legal challenge; Keryx wraps enrollment in Ph3 cancer study;

@FierceBiotech: GSK relying on Ph3 strategy in R&D comeback bid. Piece | Follow @FierceBiotech

@JohnCFierce: Worked with Cetero? FDA cites "corrupt" CRO for widespread falsification News | Follow @JohnCFierce

@RyanMFierce: If you were meeting with Biogen CEO George Scangos today, what would you ask him? Soliciting comments ahead of my trip to $BIIB in Weston. | Follow @RyanMFierce

@MaureenFierce: Ford, Toyota jump into medical device business with ECG-sensing cars. Story | Follow @MaureenFierce

> Bowing to a federal appeals court, U.S. District Judge Royce Lamberth has tossed out a controversial lawsuit challenging the Obama administration's funding of embryonic stem cell research work. A host of biotech companies and federal research officials harshly criticized Lamberth's decision to issue an injunction against the financing, saying it threatened a variety of important research projects. Story

> Keryx Biopharmaceuticals says researchers have completed patient enrollment in its Phase III registration trial of KRX-0401 (perifosine) for the treatment of advanced colorectal cancer. Release

> France's Advanced Accelerator Applications has raised €40 million to finance clinical trials of its portfolio of Radio Metabolic Therapy and diagnostic products. Release

> Sweden's Carmel Pharma AB, which bills itself as the worldwide leader in closed drug transfer systems for handling medications, says that it is being acquired by Becton Dickinson for an undisclosed sum. Release

Pharma News

@FiercePharma: Cal/OSHA fines Baxter for plant safety violations. News | Follow @FiercePharma

> Europe reviews rules on pharma-patient interaction. Article

> Teva's Q2 revenues flat on European rise, U.S. fall. Report

> Part D saved Medicare money, Harvard study finds. More

Drug Delivery News

> SPANosomes deliver siRNA more effectively More

> Zcube, Caltech get together for nanotube-needle drug delivery Article

> Nanowires are actually swimmers for drug delivery bots Story

> E-cigarrettes blasted as dangerous drug delivery devices in NEJM Item

Medical Devices News

> CareFusion to sell ResMed ventilators in U.S. Report

> Medtronic beats Boston Scientific in drug-eluting stent studies. More

> Sunshine Heart raises $5M, readies for C-pulse trials. Article

> IOM report on changes in medical devices approvals expected on Friday. News

> Toyota unveils steering-wheel ECG sensors. Story

> Report: In-home medical devices must be easier to use. Report

And Finally... Humans are the only primates whose brains shrink with age, a condition that triggers a whole laundry list of serious ailments.  Story

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.